New drug trial aims to stop dangerous bleeding in heart stent patients
Prevention
Recruiting now
This study is testing whether a new stomach-protecting drug called fexuprazan can prevent serious stomach bleeding in high-risk patients. The participants are people who have had a heart stent placed and must take two blood-thinning medications, which increases their risk of blee…
Phase: NA • Sponsor: SUK MIN SEO • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC